#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3668	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2040	349.1	0	.	n	.	0	C451T	SNP	451	451	C	630	630	T	379	T,C,A	204,65,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3668	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2040	349.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1363	1363	C	468	C,G,A	313,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3668	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2040	349.1	0	HET	.	.	.	C207T	.	207	207	C	386	386	C	332	C,T	191,48	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3668	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2040	349.1	0	HET	.	.	.	C1450T,G	.	1450	1450	C	1629	1629	C	424	C,T,G	236,50,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6858	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3575	371.4	0	.	n	.	0	T695C	SNP	695	695	T	1014	1014	C	447	C	307	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6858	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3575	371.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2290	2290	C	391	C,A	270,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6858	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3575	371.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2364	2364	A	396	A	278	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6858	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3575	371.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2916	2916	C	419	C,A	284,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	278	folP	855	855	100.0	folP.l15.c4.ctg.1	1734	35.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1125	1127	AGC	40;40;40	A;G,T;C	30;29,1;30	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3604	42.5	1	SNP	p	S91F	1	.	.	271	273	TTC	717	719	TTC	50;52;52	T;T;C	35;37;38	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3604	42.5	1	SNP	p	D95G	1	.	.	283	285	GGC	729	731	GGC	61;64;64	G;G;C	43;45;44	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3604	42.5	1	SNP	p	G95N	0	.	.	283	285	GGC	729	731	GGC	61;64;64	G;G;C	43;45;44	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	238	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1624	31.2	1	SNP	p	G45D	0	.	.	133	135	GGC	721	723	GGC	76;76;76	G;G;C	50;51;52	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	180	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1098	32.8	0	.	n	.	0	A197.	DEL	197	197	A	641	641	A	85	A,T,C	58,1,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	622	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3235	38.9	1	SNP	p	D86N	0	.	.	256	258	GAC	601	603	GAC	48;48;48	G;A;C	34;29;33	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	622	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3235	38.9	1	SNP	p	R87W	0	.	.	259	261	CGT	604	606	CGT	48;50;52	C;G;T	34;35;34	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	622	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3235	38.9	1	SNP	p	R87I	0	.	.	259	261	CGT	604	606	CGT	48;50;52	C;G;T	34;35;34	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	622	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3235	38.9	1	SNP	p	S87R	1	.	.	259	261	CGT	604	606	CGT	48;50;52	C;G;T	34;35;34	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	622	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3235	38.9	1	SNP	p	S88P	0	.	.	262	264	TCC	607	609	TCC	53;53;53	T;C;C	35;37;39	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	542	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2721	40.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1491	1493	GGC	35;36;36	G;G;C,A	25;26;23,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1458	1460	GCC	119;118;118	G;C;C	82;82;82	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1461	1463	ATG	118;118;117	A,G;T;G	81,1;82;81	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1473	1475	ACC	115;115;115	A,T,C;C;C	77,1,1;78;79	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1473	1475	ACC	115;115;115	A,T,C;C;C	77,1,1;78;79	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1974	1976	ACC	58;58;58	A;C;C	44;42;42	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2028	2030	GCG	58;58;58	G;C;G	38;34;36	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2028	2030	GCG	58;58;58	G;C;G	38;34;36	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2151	2153	GGT	48;48;46	G;G;T	33;31;32	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2160	2162	AGC	41;41;40	A;G;C	22;23;21	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	742	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2541	57.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2178	2180	CCG	31;31;31	C,G;C;G,T,C	22,1;18;20,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1264	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3062	78.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1503	1505	CCG	59;59;59	C;C;G,C	37;43;35,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	342	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1997	34.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	451	451	C	32	C	20	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	591	593	GTT	59;58;58	G;T;T	44;43;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	I75V	NONSYN	223	225	ATT	681	683	GTT	48;48;48	G;T;T	36;36;38	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	S89T	NONSYN	265	267	AGC	723	725	ACC	60;60;57	A,C;C,A;C	38,1;41,1;40	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	I98V	NONSYN	292	294	ATC	750	752	GTC	50;50;49	G;T;C	35;35;34	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	A109V	NONSYN	325	327	GCC	783	785	GTC	54;54;52	G;T;C	38;33;38	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	849	851	TAT	58;61;61	T,G,A;A;T	45,1,1;47;48	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	N134E	NONSYN	400	402	AAT	858	860	GAG	61;61;62	G;A,G;G	46;47,1;48	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	V135L	NONSYN	403	405	GTG	861	863	CTT	62;62;62	C;T;T,G	48;48;48,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	G140K	NONSYN	418	420	GGA	876	878	AAA	62;62;62	A;A;A	49;48;49	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	885	887	GGA	63;63;63	G,T,C;G;A	45,1,1;48;46	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	470	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1895	48.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	909	911	GCA	71;69;69	G,A;C;A	52,1;52;51	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1912	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5101	75.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	164	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1897	18.2	1	SNP	p	V57M	1	.	.	169	171	ATG	987	989	ATG	52;52;52	A;T;G	35;35;35	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
